▶

Building bioequivalence capacity through better business planning

Hosted by USP and the Gates Foundation, this webinar highlights how pharmaceutical manufacturers, medicines regulators, and contract research organizations (CROs) can increase regional production of generic medical products in Africa and Asia by expanding bioequivalence (BE) studies to ensure product safety, efficacy, and quality. The webinar also outlines how CROs can develop better business plans to attract investment to conduct BE studies. 
Learn more: https://www.usp.org/global-public-health/publications/business-planning-bioequivalence-studies-africa